Cure My Disease

Don't miss your cure!

Log in / Sign up

Frontometaphyseal dysplasia 2

MONDO:0014935

Any frontometaphyseal dysplasia in which the cause of the disease is a mutation in the MAP3K7 gene.

Also known as: FMD2, Frontometaphyseal dysplasia 2, Frontometaphyseal dysplasia type 2, MAP3K7 frontometaphyseal dysplasia, frontometaphyseal dysplasia 2; FMD2, frontometaphyseal dysplasia caused by mutation in MAP3K7

2 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Broader categories

Disease (717) Musculoskeletal system disorder (214) Hereditary disease (188) Bone disorder (51) Human disease (15) Skeletal system disorder (4) Disease of genetic or genomic mechanism (2) Frontometaphyseal dysplasia (2) Skeletal dysplasia (1) Disease by body system or component (0)

Not yet finished but already full! 1 Completed 1

New hope for FSHD: experimental drug AOC 1020 completes early testing

Disease control Completed

This study tested a new medicine called AOC 1020 in 90 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes muscle weakness. The goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a p…

Phase 1/2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC